Advanced Search
PACT Pharma

PACT Pharma

PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.

Edit ID  19807112 

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 4 Dec, 2020
Edits made to:
Article (+14/-14 characters)

PACT Pharma raised $95 million in Series B financing. Alphabet Inc.'s venture arm GV led the round, with participation from Invus Group, Canaan Partners, Casdin CapitalCasdin Capital, Wu Capital and other undisclosed investors.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.